ES451979A1 - Phenylethanolamine derivatives - Google Patents

Phenylethanolamine derivatives

Info

Publication number
ES451979A1
ES451979A1 ES451979A ES451979A ES451979A1 ES 451979 A1 ES451979 A1 ES 451979A1 ES 451979 A ES451979 A ES 451979A ES 451979 A ES451979 A ES 451979A ES 451979 A1 ES451979 A1 ES 451979A1
Authority
ES
Spain
Prior art keywords
formula
group
carbon atoms
groups containing
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES451979A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of ES451979A1 publication Critical patent/ES451979A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A method of preparing antiallergic compounds of formula ** (Formula) ** and their physiologically acceptable salts, R1 R2 being the same or different, and being selected from the group consisting of hydrogen, aliphatic acyl groups having 1 to 5 atoms of carbon, benzoyl, and phenylacetyl, and where A is selected from the group consisting of straight and branched alcoholic groups containing 3 to 6 carbon atoms, and cycloalcohylene groups containing 4 to 6 carbon atoms. (Machine-translation by Google Translate, not legally binding)
ES451979A 1975-10-01 1976-09-30 Phenylethanolamine derivatives Expired ES451979A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (en) 1975-10-01 1975-10-01 NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS

Publications (1)

Publication Number Publication Date
ES451979A1 true ES451979A1 (en) 1978-01-01

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
ES451979A Expired ES451979A1 (en) 1975-10-01 1976-09-30 Phenylethanolamine derivatives

Country Status (19)

Country Link
JP (1) JPS5242840A (en)
AT (1) AT347427B (en)
AU (1) AU503212B2 (en)
BE (1) BE846837A (en)
CS (2) CS199644B2 (en)
DD (1) DD126278A5 (en)
DE (1) DE2640972A1 (en)
DK (1) DK141622B (en)
ES (1) ES451979A1 (en)
FI (1) FI762660A (en)
FR (1) FR2326183A1 (en)
GB (1) GB1542317A (en)
LU (1) LU75916A1 (en)
NL (1) NL7610845A (en)
NO (1) NO763345L (en)
NZ (1) NZ182165A (en)
SE (1) SE7510988L (en)
SU (2) SU638252A3 (en)
ZA (1) ZA765331B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
EP0103830A3 (en) * 1982-09-22 1985-07-31 Bayer Ag Phenylethylemine derivatires as growth stimulators
EP2189448B1 (en) * 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Processes for the Separation of 3-Benzazepine Racemates
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (en) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ， インコーポレイテッド Process for the preparation of intermediates related to the 5-HT2C agonist (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
CN102648170A (en) 2009-06-18 2012-08-22 艾尼纳制药公司 Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
CN103189360A (en) 2010-09-01 2013-07-03 艾尼纳制药公司 Non-hygroscopic salts of 5-HT2C agonists
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
ES2704455T3 (en) 2010-09-01 2019-03-18 Arena Pharm Inc Pharmaceutical forms of modified release of 5-HT2C agonists useful for weight management
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
CS199643B2 (en) 1980-07-31
NL7610845A (en) 1977-04-05
SU674669A3 (en) 1979-07-15
GB1542317A (en) 1979-03-14
AT347427B (en) 1978-12-27
SU638252A3 (en) 1978-12-15
AU1812276A (en) 1978-04-06
DD126278A5 (en) 1977-07-06
DE2640972A1 (en) 1977-04-14
ATA682376A (en) 1978-05-15
LU75916A1 (en) 1978-05-16
BE846837A (en) 1977-04-01
AU503212B2 (en) 1979-08-30
JPS5242840A (en) 1977-04-04
FR2326183A1 (en) 1977-04-29
DK141622B (en) 1980-05-12
FI762660A (en) 1977-04-02
DK439776A (en) 1977-04-02
CS199644B2 (en) 1980-07-31
NZ182165A (en) 1978-07-10
ZA765331B (en) 1977-08-31
SE7510988L (en) 1977-04-02
NO763345L (en) 1977-04-04

Similar Documents

Publication Publication Date Title
ES8604559A1 (en) Blood-pressure lowering piperazine derivatives.
ES462061A1 (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
ES456287A1 (en) Polyoxygenated labdane derivatives
ES451979A1 (en) Phenylethanolamine derivatives
ES8104321A1 (en) Alkyl-ketohexopyrand-side derivatives and method of use
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
GB1369248A (en) Amides the preparation thereof and their use in pharmacjeutical compositions
IE43847L (en) N-substituted phenylpiperidine derivatives.
ES454084A1 (en) Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding)
SE7608608L (en) PROCEDURE FOR MAKING NEW DIAMINO ANDROSTANES
ES472276A1 (en) Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them
ES463682A1 (en) Derivatives of coenzyme B12
IE43830L (en) Phenylpiperidine derivatives.
ES451466A1 (en) 5-thiazole-methane-amines, and their use as antilipolytics
ES446187A1 (en) Oxime ethers having anti-depressive activity
GB1532551A (en) Furo(3,4-6)furone derivatives and their preparation
FR2356658A1 (en) PROCESS FOR THE PRODUCTION OF SUBSTITUTED ALIPHATIC PHOSPHINICO-CARBOXYLIC ACIDS
ES439080A1 (en) Diebenzo(B,E)thiepines
ES364980A1 (en) A method for preparing new adamantan derivatives. (Machine-translation by Google Translate, not legally binding)
ES442051A1 (en) Aminoglycosides
ES401342A1 (en) Pyridine derivatives
ES446874A1 (en) Novel chromone derivatives
ES444005A2 (en) Salts of 2-alkylthiazole-5-methanol derivatives
ES459400A1 (en) 6,11-dihydrodibenzo - thiepin - 11 - ones methods of preparation compositions and uses thereof
ES401174A1 (en) 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor